1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015

Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015" provides data on the Islet Cell Carcinoma (Insulinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Islet Cell Carcinoma (Insulinoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Islet Cell Carcinoma (Insulinoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Islet Cell Carcinoma (Insulinoma) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Islet Cell Carcinoma (Insulinoma) 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Eli Lilly and Company 35
Clinical Trial Overview of Eli Lilly and Company 35
XOMA Corporation 36
Clinical Trial Overview of XOMA Corporation 36
Burzynski Research Institute, Inc. 37
Clinical Trial Overview of Burzynski Research Institute, Inc. 37
Clinical Trial Overview of Top Institutes / Government 38
National Cancer Institute 38
Clinical Trial Overview of National Cancer Institute 38
Eastern Cooperative Oncology Group 39
Clinical Trial Overview of Eastern Cooperative Oncology Group 39
Memorial Sloan Kettering Cancer Center 40
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 40
Vanderbilt-Ingram Cancer Center 41
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 41
Northwestern University 42
Clinical Trial Overview of Northwestern University 42
University of Southern California 43
Clinical Trial Overview of University of Southern California 43
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
Sidney Kimmel Comprehensive Cancer Center 45
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 45
Stanford University 46
Clinical Trial Overview of Stanford University 46
Five Key Clinical Profiles 47
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106

List of Tables
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Islet Cell Carcinoma (Insulinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Islet Cell Carcinoma (Insulinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Islet Cell Carcinoma (Insulinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Islet Cell Carcinoma (Insulinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Islet Cell Carcinoma (Insulinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 35
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015* 36
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2015* 37
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 38
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015* 39
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 40
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2015* 41
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 42
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015* 43
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 44
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2015* 45
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 46

List of Figures
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Islet Cell Carcinoma (Insulinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Islet Cell Carcinoma (Insulinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Islet Cell Carcinoma (Insulinoma) to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Islet Cell Carcinoma (Insulinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Islet Cell Carcinoma (Insulinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Islet Cell Carcinoma (Insulinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Islet Cell Carcinoma (Insulinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Islet Cell Carcinoma (Insulinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • October 2016
  • by Global Data

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline ...

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.